Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K/A | 10-K/A | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues: |
Maintenance income | | | | | | 0.2 | | |
Other | | | | | | 3.2 | | |
Revenues [+] | 1.1 | 3.2 | 3.1 | 3.4 | 3.4 | 3.5 | 3.0 | 2.6 |
Healthcare | | | | | | 3.2 | 3.0 | 2.6 |
Revenue growth | -66.6% | 3.4% | -10.3% | 0.3% | -1.2% | 16.4% | 14.0% | 6417.5% |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 |
Gross profit | 1.1 | 3.2 | 3.1 | 3.4 | 3.4 | 3.2 | 3.0 | 2.6 |
Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 92.9% | 100.0% | 100.0% |
Selling, general and administrative | 1.1 | 1.2 | 1.2 | 1.3 | 1.3 | 1.3 | 1.2 | 1.2 |
Equity in earnings | -0.5 | -0.8 | -1.4 | -0.7 | -0.1 | 0.6 | 0.3 | 0.0 |
Other operating expenses | 0.1 | 0.4 | 0.4 | 2.0 | 1.5 | 1.5 | 1.2 | 0.7 |
EBITDA [+] | | | | 0.4 | 1.7 | 2.0 | 1.8 | 1.4 |
EBITDA growth | -169.2% | 675.0% | -72.0% | -78.5% | -15.6% | 15.6% | 24.1% | -238.7% |
EBITDA margin | -52.6% | 25.4% | 3.4% | 10.8% | 50.4% | 59.0% | 59.4% | 54.5% |
Depreciation and amortization | | | | 1.0 | 1.1 | 1.0 | 0.9 | 0.7 |
EBIT [+] | -0.6 | 0.8 | 0.1 | -0.6 | 0.6 | 1.0 | 0.8 | 0.8 |
EBIT growth | -169.2% | 675.0% | -117.0% | -204.3% | -43.2% | 24.7% | 10.5% | -173.2% |
EBIT margin | -52.6% | 25.4% | 3.4% | -17.9% | 17.2% | 29.9% | 27.9% | 28.8% |
Non-recurring items [+] | | | | | | -0.2 | | |
Asset impairment | | | | | | -0.2 | | |
Loss (gain) on sale of assets | | | | 0.7 | | | | |
Interest expense, net [+] | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.2 | 0.2 | 0.2 |
Interest expense | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 |
Interest income | | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | | |
Other income (expense), net | 0.0 | 0.1 | 0.1 | 0.0 | | -0.2 | | 0.2 |
Pre-tax income | -0.6 | 0.9 | 0.2 | -0.6 | 0.4 | 0.9 | 0.6 | 0.8 |
Income taxes | 0.4 | 0.3 | 0.0 | -0.2 | -0.1 | 0.3 | 0.3 | 0.2 |
Tax rate | | 37.7% | 6.0% | 31.3% | | 39.0% | 38.9% | 30.1% |
Minority interest | -0.1 | | | | | | | |
Net income | -0.9 | 0.5 | 0.1 | -0.4 | 0.5 | 0.5 | 0.4 | 0.6 |
Net margin | -83.0% | 16.8% | 4.6% | -12.3% | 15.8% | 15.5% | 13.3% | 21.5% |
|
Basic EPS [+] | ($0.11) | $0.07 | $0.02 | ($0.05) | $0.07 | $0.07 | $0.05 | $0.07 |
Growth | -265.3% | 275.4% | -133.7% | -178.3% | 0.4% | 35.4% | -29.4% | -184.1% |
Diluted EPS [+] | ($0.11) | $0.07 | $0.02 | ($0.05) | $0.07 | $0.07 | $0.05 | $0.07 |
Growth | -265.3% | 275.4% | -133.7% | -178.3% | 0.4% | 35.4% | -29.4% | -184.1% |
|
Shares outstanding (basic) [+] | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Shares outstanding (diluted) [+] | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 | 7.8 |
Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|